Generic name: formoterol fumarate

Brand names: AeroBid, Foradil

Formulations:

  • MDI: 42 mcg per puff (200 puffs per canister)
  • DPI: 90 mcg per inhalation (60 inhalations per canister)

AeroBid is a prescription medication that is used to prevent the symptoms of asthma. It is a long-acting beta2-adrenergic agonist (LABA) that works by relaxing the muscles in the airways to improve breathing. AeroBid is typically used in conjunction with an inhaled corticosteroid (ICS) and is available in both metered-dose inhaler (MDI) and dry powder inhaler (DPI) formulations.

AeroBid is generally well tolerated, with the most common side effects being throat irritation and coughing. Some people may also experience increased heart rate and tremor. AeroBid should not be used by people with certain medical conditions, such as uncontrolled high blood pressure, heart disease, or seizures. It is also not recommended for women who are pregnant or breastfeeding.

If you are considering AeroBid for the treatment of your asthma, talk to your doctor about the potential risks and benefits. AeroBid may not be the best option for everyone, but it can be an effective treatment for many people with asthma.

AeroBid

Pharmacokinetics

AeroBid (formoterol fumarate) is a long-acting beta2-adrenergic agonist (LABA). Formoterol is the active ingredient in AeroBid, and it is structurally similar to other beta2-agonists such as albuterol (Proventil, Ventolin).

Formoterol is rapidly absorbed from the lungs into the bloodstream and has an onset of action within minutes. The peak effect of formoterol occurs within 1-3 hours, and the duration of action is 6-12 hours. Formoterol is eliminated from the body via metabolism and excretion in the urine.

AeroBid is available in both metered-dose inhaler (MDI) and dry powder inhaler (DPI) formulations. The MDI formulation delivers 42 mcg of formoterol per puff, and the DPI formulation delivers 90 mcg of formoterol per inhalation.

Indications

AeroBid is FDA-approved for the prevention of bronchospasm in people with asthma. AeroBid is typically used in conjunction with an inhaled corticosteroid (ICS), and it is not recommended for use as a rescue medication.

Side Effects

The most common side effects of AeroBid are throat irritation and cough. Some people may also experience increased heart rate, tremor, and headache.

AeroBid should not be used by people with certain medical conditions, such as uncontrolled high blood pressure, heart disease, or seizures. It is also not recommended for women who are pregnant or breastfeeding.

Warnings and Precautions

AeroBid can interact with other medications, so it is important to tell your doctor about all the drugs you are taking, including over-the-counter medications, vitamins, and herbal supplements.

AeroBid may not be the best option for everyone, so talk to your doctor about the potential risks and benefits of using AeroBid to treat your asthma.

Pregnancy and Breastfeeding

AeroBid is not recommended for use by women who are pregnant or breastfeeding. Talk to your doctor about the risks and benefits of using AeroBid if you are pregnant or breastfeeding.

Dosage

AeroBid is available in two strengths: an MDI containing 42 mcg of formoterol per puff, and a DPI containing 90 mcg of formoterol per inhalation.

The recommended starting dose of AeroBid is one puff (42 mcg) twice daily. If needed, the dose may be increased to two puffs (84 mcg) twice daily. The maximum daily dose of AeroBid is four puffs (168 mcg).

For the DPI formulation, the recommended starting dose is one or two inhalations (90-180 mcg) twice daily. If needed, the dose may be increased to four inhalations (360 mcg) twice daily. The maximum daily dose of AeroBid DPI is eight inhalations (720 mcg).

Overdose

There is no specific treatment for an overdose of AeroBid. If you or someone you know has overdosed on AeroBid, call 911 or go to the nearest emergency room.